Enabling the systematic design, cloning, and testing of large numbers
of bi- and multi-specifics, such as knobs-into-holes (KinH), Fab-scFv, IgG-scFv, DuoBody, DVD-Ig, tandem-scFv-Fc and their parametric variants (e.g., linkers, V-domain order, Fc).
Bispecific Antibody Engineering
Genedata Biologics automates downstream expression, purification, and characterization processes, which substantially increases throughput. By identifying the most successful combination of antigen binders and formats, the platform resolves major bottlenecks in high-throughput molecular biology and cloning processes and directly integrates with laboratory automation equipment to scale up cloning and production. With the automatic aggregation of all assay and analytics results, the platform also enables multi-parameter lead selection.
Genedata Biologics gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow.
Dominik Maurer, Ph.D.
Given their track-record of success, Genedata’s platform was the clear choice to support and integrate our full cell therapy discovery and development efforts.
Marc Van Dijk, Ph.D.
Chief Technology Officer
Scaling-Up Bispecific Antibody Discovery
“We are rapidly expanding our biotherapeutic R&D activities and needed a scalable, flexible platform that we could quickly and easily implement. We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D.”
GSK Implements Genedata Biologics as Antibody Discovery Platform
Genedata and GSK will work together to support new discovery technologies and next-generation antibody formats such as GSK’s domain antibodies and other proprietary molecules and technologies.
Genedata Accelerates Antibody Discovery at BI
"We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice."
MorphoSys Accelerates Antibody R&D with Genedata Biologics
"We made a decision early on to use Genedata Biologics as MorphoSys’ workflow backbone to accelerate our drug discovery efforts and have watched as Genedata Biologics has become the global industry standard for biopharma discovery organizations."